Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
AI and Machine Learning
WuXi Bio's contracting business saw influx of US clients in '25
Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025.
Fraiser Kansteiner
Mar 24, 2026 10:56am
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
China's BCI nod, AZ, Astellas—Fierce Pharma Asia
Mar 20, 2026 8:00am
AZ to build cell therapy supply hub, R&D center in Shanghai
Mar 19, 2026 10:20am
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Mar 13, 2026 8:05am
Lilly commits $3B to China manufacturing expansions
Mar 11, 2026 11:38am
